These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15267131)

  • 1. Role of lipid and lipoprotein metabolizing enzymes in the development of atherosclerosis.
    Subramanian R; Ramaswamy M; Wasan KM
    Indian J Exp Biol; 2003 Jan; 41(1):14-25. PubMed ID: 15267131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoproteins and atherosclerosis in children: an early marriage?
    Strong JP; Zieske AW; Malcom GT
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11 Suppl 5():16-22. PubMed ID: 12063771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary prevention of atherosclerosis through chlamydia pneumoniae eradication (SPACE Trial): a randomised clinical trial in patients with peripheral arterial disease.
    Vainas T; Stassen FR; Schurink GW; Tordoir JH; Welten RJ; van den Akker LH; Kurvers HA; Bruggeman CA; Kitslaar PJ
    Eur J Vasc Endovasc Surg; 2005 Apr; 29(4):403-11. PubMed ID: 15749042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender-specific characteristics of atherosclerosis in menopausal women: risk factors, clinical course and strategies for prevention.
    Vitale C; Miceli M; Rosano GM
    Climacteric; 2007 Oct; 10 Suppl 2():16-20. PubMed ID: 17882667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The heart of women].
    Gruppo di Lavoro della Società Italiana di Cardiologia
    G Ital Cardiol (Rome); 2007 Jan; 8(1):3-27. PubMed ID: 17354628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal risk factor modification and medical management of the patient with peripheral arterial disease.
    Chi YW; Jaff MR
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):475-89. PubMed ID: 18307227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
    Cersosimo E; DeFronzo RA
    Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying the vulnerable patient with rupture-prone plaque.
    Weintraub HS
    Am J Cardiol; 2008 Jun; 101(12A):3F-10F. PubMed ID: 18549869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary and secondary disorders of lipid metabolism in pediatrics.
    Kwiterovich PO
    Pediatr Endocrinol Rev; 2008 Feb; 5 Suppl 2():727-38. PubMed ID: 18317444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of cardiovascular risk factors and complications before and after kidney transplantation.
    Fazelzadeh A; Mehdizadeh A; Ostovan MA; Raiss-Jalali GA
    Transplant Proc; 2006 Mar; 38(2):506-8. PubMed ID: 16549161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention.
    Chapman MJ
    Pharmacol Ther; 2007 Jan; 113(1):184-96. PubMed ID: 17070923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein (a) and risk of ischemic stroke in young adults.
    Rigal M; Ruidavets JB; Viguier A; Petit R; Perret B; Ferrieres J; Larrue V
    J Neurol Sci; 2007 Jan; 252(1):39-44. PubMed ID: 17113602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current data on the pathogenesis of atherosclerosis].
    Nicolaescu V; Cerchez T
    Med Interna (Bucur); 1971 Mar; 23(3):303-12. PubMed ID: 5574927
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sleep apnea syndromes and cardiovascular disease].
    Bounhoure JP; Galinier M; Didier A; Leophonte P
    Bull Acad Natl Med; 2005 Mar; 189(3):445-59; discussion 460-4. PubMed ID: 16149210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report.
    Naghavi M; Falk E; Hecht HS; Jamieson MJ; Kaul S; Berman D; Fayad Z; Budoff MJ; Rumberger J; Naqvi TZ; Shaw LJ; Faergeman O; Cohn J; Bahr R; Koenig W; Demirovic J; Arking D; Herrera VL; Badimon J; Goldstein JA; Rudy Y; Airaksinen J; Schwartz RS; Riley WA; Mendes RA; Douglas P; Shah PK;
    Am J Cardiol; 2006 Jul; 98(2A):2H-15H. PubMed ID: 16843744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid and lipoprotein metabolism in chronic kidney disease.
    Kaysen GA
    J Ren Nutr; 2009 Jan; 19(1):73-7. PubMed ID: 19121776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of prevention and treatment of atherosclerosis with lipid-altering therapy for pharmacy directors.
    Davidson MH
    Am J Manag Care; 2007 Dec; 13 Suppl 10():S260-9. PubMed ID: 18095776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid diseases, dyslipidemia and cardiovascular pathology.
    Neves C; Alves M; Medina JL; Delgado JL
    Rev Port Cardiol; 2008 Oct; 27(10):1211-36. PubMed ID: 19178025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiovascular comorbidity in rheumatic disease. Does sex play a role?].
    Kung M; Störk S; Angermann CE
    Herz; 2005 Sep; 30(6):512-21. PubMed ID: 16170682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of cardiovascular risk factors with pattern of lower limb atherosclerosis in 2659 patients undergoing angioplasty.
    Diehm N; Shang A; Silvestro A; Do DD; Dick F; Schmidli J; Mahler F; Baumgartner I
    Eur J Vasc Endovasc Surg; 2006 Jan; 31(1):59-63. PubMed ID: 16269257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.